{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T08:03:18Z","timestamp":1780041798283,"version":"3.53.1"},"reference-count":79,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Dermatology"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.clindermatol.2026.04.005","type":"journal-article","created":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T16:23:49Z","timestamp":1775579029000},"page":"393-400","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Skin cancer and vitamins: In theory and practice"],"prefix":"10.1016","volume":"44","author":[{"given":"Uwe","family":"Wollina","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clindermatol.2026.04.005_bib0001","doi-asserted-by":"crossref","DOI":"10.1016\/j.envres.2024.118117","article-title":"Epidemiological and clinical analysis of exposure-related factors in non-melanoma skin cancer: a retrospective cohort study","volume":"247","author":"Artosi","year":"2024","journal-title":"Environ Res"},{"key":"10.1016\/j.clindermatol.2026.04.005_bib0002","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1001\/jamadermatol.2022.0263","article-title":"UV exposure and the risk of keratinocyte carcinoma in skin of color: a systematic review","volume":"158","author":"Kolitz","year":"2022","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.clindermatol.2026.04.005_bib0003","doi-asserted-by":"crossref","DOI":"10.1016\/j.envint.2023.108226","volume":"181","author":"Pega","year":"2023","journal-title":"Environ Int"},{"key":"10.1016\/j.clindermatol.2026.04.005_bib0004","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1001\/jamadermatol.2020.4616","article-title":"UV exposure and the risk of cutaneous melanoma in skin of color: a systematic review","volume":"157","author":"Lopes","year":"2021","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.clindermatol.2026.04.005_bib0005","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1080\/02841860410031372","article-title":"Primary malignant melanoma of the vulva \u2013 an aggressive tumor for modeling the genesis of non-UV light-associated melanomas","volume":"43","author":"Ragnarsson-Olding","year":"2004","journal-title":"Acta Oncol"},{"key":"10.1016\/j.clindermatol.2026.04.005_bib0006","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1001\/jamadermatol.2022.0160","article-title":"Global burden of cutaneous melanoma in 2020 and projections to 2040","volume":"158","author":"Arnold","year":"2022","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.clindermatol.2026.04.005_bib0007","doi-asserted-by":"crossref","first-page":"13765","DOI":"10.1073\/pnas.0604213103","article-title":"Cyclobutane pyrimidine dimers are predominant DNA lesions in whole human skin exposed to UVA radiation","volume":"103","author":"Mouret","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.clindermatol.2026.04.005_bib0008","doi-asserted-by":"crossref","first-page":"26732","DOI":"10.1016\/S0021-9258(19)61437-7","article-title":"Distribution and repair of bipyrimidine photoproducts in solar UV-irradiated mammalian cells. Possible role of Dewar photoproducts in solar mutagenesis","volume":"275","author":"Perdiz","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1016\/j.clindermatol.2026.04.005_bib0009","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/j.saa.2005.10.013","article-title":"Measurements of UV-generated free radicals\/reactive oxygen species (ROS) in skin","volume":"63","author":"Herrling","year":"2006","journal-title":"Spectrochim Acta A Mol Biomol Spectrosc"},{"key":"10.1016\/j.clindermatol.2026.04.005_bib0010","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1038\/jid.2011.476","article-title":"Irradiation of skin with visible light induces reactive oxygen species and matrix-degrading enzymes","volume":"132","author":"Liebel","year":"2012","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.clindermatol.2026.04.005_bib0011","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1038\/sj.jid.5700340","article-title":"Oxidative stress in the pathogenesis of skin disease","volume":"126","author":"Bickers","year":"2006","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.clindermatol.2026.04.005_bib0012","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1111\/phpp.12899","article-title":"The effects of infrared radiation on the human skin","volume":"39","author":"Horton","year":"2023","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"10.1016\/j.clindermatol.2026.04.005_bib0013","article-title":"Cutaneous radical scavenging effects of orally administered antioxidants measured by electron paramagnetic resonance spectroscopy","volume":"7","author":"Meinke","year":"2012","journal-title":"ESPEN J"},{"key":"10.1016\/j.clindermatol.2026.04.005_bib0014","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jdermsci.2006.07.001","article-title":"A new lipophilic pro-vitamin C, tetra-isopalmitoyl ascorbic acid (VC-IP), prevents UV-induced skin pigmentation through its anti-oxidative properties","volume":"44","author":"Ochiai","year":"2006","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.clindermatol.2026.04.005_bib0015","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.clnesp.2020.12.001","article-title":"Vitamin D, the natural way","volume":"41","author":"Aguilar-Shea","year":"2021","journal-title":"Clin Nutr ESPEN"},{"key":"10.1016\/j.clindermatol.2026.04.005_bib0016","first-page":"1","article-title":"Deciphering the role of vitamin D on skin cancers and tumour microenvironment","author":"Nautiyal","year":"2023","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"10.1016\/j.clindermatol.2026.04.005_bib0017","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1080\/01635589609514475","article-title":"Disposition and metabolism of topically administered alpha-tocopherol acetate: a common ingredient of commercially available sunscreens and cosmetics","volume":"26","author":"Alberts","year":"1996","journal-title":"Nutr Cancer"},{"key":"10.1016\/j.clindermatol.2026.04.005_bib0018","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1038\/jid.2011.483","article-title":"Tretinoin and the prevention of keratinocyte carcinoma (basal and squamous cell carcinoma of the skin): a Veterans Affairs randomized chemoprevention trial","volume":"132","author":"Weinstock","year":"2012","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.clindermatol.2026.04.005_bib0019","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1158\/1940-6207.CAPR-13-0305","article-title":"Tazarotene: randomized, double-blind, vehicle-controlled, and open-label concurrent trials for basal cell carcinoma prevention and therapy in patients with basal cell nevus syndrome","volume":"7","author":"Tang","year":"2014","journal-title":"Cancer Prev Res (Phila)"},{"key":"10.1016\/j.clindermatol.2026.04.005_bib0020","article-title":"Associations between dietary and supplemental vitamin A intake and melanoma and non-melanoma skin cancer","volume":"4","author":"Mittal","year":"2024","journal-title":"Skin Health Dis"},{"key":"10.1016\/j.clindermatol.2026.04.005_bib0021","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.jid.2025.06.1577","article-title":"No evidence that genetically predicted circulating retinol is protective for skin cancer","volume":"146","author":"Helder","year":"2026","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.clindermatol.2026.04.005_bib0022","first-page":"949","article-title":"Effect of retinol in preventing squamous cell skin cancer in moderate-risk subjects: a randomized, double-blind, controlled trial. Southwest Skin Cancer Prevention Study Group","volume":"6","author":"Moon","year":"1997","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.clindermatol.2026.04.005_bib0023","first-page":"957","article-title":"Trial of retinol and isotretinoin in skin cancer prevention: a randomized, double-blind, controlled trial. Southwest Skin Cancer Prevention Study Group","volume":"6","author":"Levine","year":"1997","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.clindermatol.2026.04.005_bib0024","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1093\/jnci\/84.5.328","article-title":"Long-term therapy with low-dose isotretinoin for prevention of basal cell carcinoma: a multicenter clinical trial. Isotretinoin-Basal Cell Carcinoma Study Group","volume":"84","author":"Tangrea","year":"1992","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.clindermatol.2026.04.005_bib0025","doi-asserted-by":"crossref","first-page":"225","DOI":"10.36849\/JDD.5721","article-title":"Acitretin for secondary prevention of keratinocyte cancers in a veteran population: a retrospective cohort study","volume":"20","author":"Lim","year":"2021","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.clindermatol.2026.04.005_bib0026","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1001\/archderm.141.4.456","article-title":"Low-dose retinoids in the prevention of cutaneous squamous cell carcinomas in organ transplant recipients: a 16-year retrospective study","volume":"141","author":"Harwood","year":"2005","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2026.04.005_bib0027","doi-asserted-by":"crossref","first-page":"3446","DOI":"10.3390\/molecules14093446","article-title":"The vitamin nicotinamide: translating nutrition into clinical care","volume":"14","author":"Maiese","year":"2009","journal-title":"Molecules"},{"key":"10.1016\/j.clindermatol.2026.04.005_bib0028","doi-asserted-by":"crossref","DOI":"10.4061\/2010\/157591","article-title":"Role of nicotinamide in DNA damage, mutagenesis, and DNA repair","volume":"2010","author":"Surjana","year":"2010","journal-title":"J Nucleic Acids"},{"key":"10.1016\/j.clindermatol.2026.04.005_bib0029","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1002\/ijc.30630","article-title":"Niacin intake and risk of skin cancer in US women and men","volume":"140","author":"Park","year":"2017","journal-title":"Int J Cancer"},{"key":"10.1016\/j.clindermatol.2026.04.005_bib0030","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1111\/j.1365-2133.2010.09659.x","article-title":"Randomized, double-blinded, placebo controlled study to assess the effect of topical 1% nicotinamide on actinic keratoses","volume":"162","author":"Moloney","year":"2010","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2026.04.005_bib0031","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1056\/NEJMoa1506197","article-title":"A phase 3 randomized trial of nicotinamide for skin-cancer chemoprevention","volume":"373","author":"Chen","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clindermatol.2026.04.005_bib0032","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1111\/bjd.14662","article-title":"A phase II randomized controlled trial of nicotinamide for skin cancer chemoprevention in renal transplant recipients","volume":"175","author":"Chen","year":"2016","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2026.04.005_bib0033","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1056\/NEJMoa2203086","article-title":"Nicotinamide for skin-cancer chemoprevention in transplant recipients","volume":"388","author":"Allen","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clindermatol.2026.04.005_bib0034","doi-asserted-by":"crossref","first-page":"100","DOI":"10.3390\/nu16010100","article-title":"The role of nicotinamide as chemo-preventive agent in NMSCs: a systematic review and meta-analysis","volume":"16","author":"Tosti","year":"2023","journal-title":"Nutrients"},{"key":"10.1016\/j.clindermatol.2026.04.005_bib0035","first-page":"1","article-title":"Exploring vitamin D metabolism and function in cancer","volume":"50","author":"Jeon","year":"2018","journal-title":"Exp Mol Med"},{"key":"10.1016\/j.clindermatol.2026.04.005_bib0036","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.clnesp.2023.07.005","article-title":"Prevalence of vitamin D deficiency in seniors - a retrospective study","volume":"57","author":"Haitchi","year":"2023","journal-title":"Clin Nutr ESPEN"},{"key":"10.1016\/j.clindermatol.2026.04.005_bib0037","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.jsbmb.2012.09.021","article-title":"Protective role of vitamin D signaling in skin cancer formation","volume":"136","author":"Bikle","year":"2013","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1016\/j.clindermatol.2026.04.005_bib0038","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1158\/1940-6207.CAPR-10-0285","article-title":"Vitamin D3 inhibits hedgehog signaling and proliferation in murine basal cell carcinomas","volume":"4","author":"Tang","year":"2011","journal-title":"Cancer Prev Res (Phila)"},{"key":"10.1016\/j.clindermatol.2026.04.005_bib0039","doi-asserted-by":"crossref","DOI":"10.29219\/fnr.v67.10230","article-title":"Vitamin D - a scoping review for Nordic nutrition recommendations 2023","volume":"67","author":"Brustad","year":"2023","journal-title":"Food Nutr Res"},{"key":"10.1016\/j.clindermatol.2026.04.005_bib0040","doi-asserted-by":"crossref","first-page":"5083","DOI":"10.21873\/anticanres.16017","article-title":"High oral vitamin D3 intake does not protect against UVR-induced squamous cell carcinoma in mice","volume":"42","author":"Lerche","year":"2022","journal-title":"Anticancer Res"},{"key":"10.1016\/j.clindermatol.2026.04.005_bib0041","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s12672-019-00365-2","article-title":"Assessing the effect of vitamin D replacement on basal cell carcinoma occurrence and recurrence rates in patients with vitamin D deficiency","volume":"10","author":"Ince","year":"2019","journal-title":"Horm Cancer"},{"key":"10.1016\/j.clindermatol.2026.04.005_bib0042","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.3390\/antiox12051107","article-title":"Non-melanoma skin cancer and vitamin D: the \u201clost sunlight\u201d paradox and the oxidative stress explanation","volume":"12","author":"Karampinis","year":"2023","journal-title":"Antioxidants (Basel)"},{"key":"10.1016\/j.clindermatol.2026.04.005_bib0043","article-title":"Dissection of an impact of VDR and RXRA on the genomic activity of 1,25(OH)2D3 in A431 squamous cell carcinoma","volume":"582","author":"Olszewska","year":"2023","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.clindermatol.2026.04.005_bib0044","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1111\/bjd.21742","article-title":"The effect of vitamin D supplementation on risk of keratinocyte cancer: an exploratory analysis of the D-Health randomized controlled trial","volume":"187","author":"Ali","year":"2022","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2026.04.005_bib0045","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.3390\/medicina59122130","article-title":"The association of vitamin D with non-melanoma skin cancer risk: an umbrella review of systematic reviews and meta-analyses","volume":"59","author":"Seretis","year":"2023","journal-title":"Medicina (Kaunas)"},{"key":"10.1016\/j.clindermatol.2026.04.005_bib0046","first-page":"5019","article-title":"Calcitriol inhibits arsenic-promoted tumorigenesis through regulation of arsenic-uptake in a human keratinocyte cell line","volume":"12","author":"Yajima","year":"2022","journal-title":"Am J Cancer Res"},{"key":"10.1016\/j.clindermatol.2026.04.005_bib0047","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-70078-y","article-title":"25-Hydroxyvitamin D status, vitamin D intake, and skin cancer risk: a systematic review and dose-response meta-analysis of prospective studies","volume":"10","author":"Mahamat-Saleh","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.clindermatol.2026.04.005_bib0048","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1097\/CMR.0000000000000870","article-title":"Regular use of vitamin D supplement is associated with fewer melanoma cases compared to non-use: a cross-sectional study in 498 adult subjects at risk of skin cancers","volume":"33","author":"Kanasuo","year":"2023","journal-title":"Melanoma Res"},{"key":"10.1016\/j.clindermatol.2026.04.005_bib0049","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/cup.14771","article-title":"The roles of vitamin D receptor (VDR) and CD8+ T-lymphocytes in acral and mucosal melanoma invasion depth","volume":"52","author":"Usman","year":"2025","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.clindermatol.2026.04.005_bib0050","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.jid.2019.05.033","article-title":"Environmental exposures such as smoking and low vitamin D are predictive of poor outcome in cutaneous melanoma rather than other deprivation measures","volume":"140","author":"Hardie","year":"2020","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.clindermatol.2026.04.005_bib0051","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1097\/CMR.0000000000000897","article-title":"Vitamin D insufficiency and serum levels related to the incidence and stage of cutaneous melanoma: a systematic review and meta-analysis","volume":"33","author":"Shellenberger","year":"2023","journal-title":"Melanoma Res"},{"key":"10.1016\/j.clindermatol.2026.04.005_bib0052","doi-asserted-by":"crossref","first-page":"27","DOI":"10.21873\/anticanres.17390","article-title":"Malignant melanoma: vitamin D status as a risk and prognostic factor \u2013 meta-analyses and systematic review","volume":"45","author":"Haddad","year":"2025","journal-title":"Anticancer Res"},{"key":"10.1016\/j.clindermatol.2026.04.005_bib0053","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1093\/bjd\/ljae257","article-title":"High-dose vitamin D supplementation does not improve outcome in a cutaneous melanoma population: results of a randomized double-blind placebo-controlled study (ViDMe trial)","volume":"191","author":"De Smedt","year":"2024","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2026.04.005_bib0054","first-page":"519","article-title":"Oral supplements and photoprotection: a systematic review","volume":"28","author":"Natarelli","year":"2025","journal-title":"J Med Food"},{"key":"10.1016\/j.clindermatol.2026.04.005_bib0055","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.canlet.2016.03.042","article-title":"Reactive oxygen species (ROS) and cancer: role of antioxidative nutraceuticals","volume":"387","author":"Prasad","year":"2017","journal-title":"Cancer Lett"},{"key":"10.1016\/j.clindermatol.2026.04.005_bib0056","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1024\/0300-9831\/a000171","article-title":"Association between dietary vitamin C and risk of cutaneous melanoma in a population of Northern Italy","volume":"83","author":"Malavolti","year":"2013","journal-title":"Int J Vitam Nutr Res"},{"key":"10.1016\/j.clindermatol.2026.04.005_bib0057","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1038\/sj.bjc.6600882","article-title":"Dietary intakes of vitamins A, C, and E and risk of melanoma in two cohorts of women","volume":"88","author":"Feskanich","year":"2003","journal-title":"Br J Cancer"},{"key":"10.1016\/j.clindermatol.2026.04.005_bib0058","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2023.102619","article-title":"ROS-lowering doses of vitamins C and A accelerate malignant melanoma metastasis","volume":"60","author":"Kashif","year":"2023","journal-title":"Redox Biol"},{"key":"10.1016\/j.clindermatol.2026.04.005_bib0059","doi-asserted-by":"crossref","first-page":"4018","DOI":"10.3390\/nu13114018","article-title":"Nutritional interventions for patients with melanoma: from prevention to therapy-an update","volume":"13","author":"Pellegrini","year":"2021","journal-title":"Nutrients"},{"key":"10.1016\/j.clindermatol.2026.04.005_bib0060","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1056\/NEJM199912023412312","article-title":"Preliminary observations on the use of topical tazarotene to treat basal-cell carcinoma","volume":"341","author":"Peris","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clindermatol.2026.04.005_bib0061","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1046\/j.1523-1747.2003.12488.x","article-title":"Tazarotene-induced gene 3 is suppressed in basal cell carcinomas and reversed in vivo by tazarotene application","volume":"121","author":"Duvic","year":"2003","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.clindermatol.2026.04.005_bib0062","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s00403-020-02152-4","article-title":"Oral isotretinoin for the treatment of dermatologic conditions other than acne: a systematic review and discussion of future directions","volume":"313","author":"Chu","year":"2021","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.clindermatol.2026.04.005_bib0063","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/jnci\/84.4.235","article-title":"13-cis-retinoic acid and interferon \u03b1-2a: effective combination therapy for advanced squamous cell carcinoma of the skin","volume":"84","author":"Lippman","year":"1992","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.clindermatol.2026.04.005_bib0064","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1093\/oxfordjournals.annonc.a058881","article-title":"Efficacy of recombinant alpha-interferon 2a and 13-cis-retinoic acid in the treatment of squamous cell carcinoma","volume":"5","author":"Toma","year":"1994","journal-title":"Ann Oncol"},{"key":"10.1016\/j.clindermatol.2026.04.005_bib0065","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.clindermatol.2009.06.010","article-title":"Keratoacanthoma: facts and controversies","volume":"28","author":"Ko","year":"2010","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.clindermatol.2026.04.005_bib0066","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/S0190-9622(84)80331-X","article-title":"Multiple persistent keratoacanthomas: treatment with oral etretinate","volume":"10","author":"Benoldi","year":"1984","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2026.04.005_bib0067","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/0190-9622(90)70305-2","article-title":"Multiple keratoacanthomas treated with oral retinoids","volume":"23","author":"Street","year":"1990","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2026.04.005_bib0068","first-page":"30","article-title":"An updated review of the therapeutic management of keratoacanthomas","volume":"15","author":"Ambur","year":"2022","journal-title":"J Clin Aesthet Dermatol"},{"key":"10.1016\/j.clindermatol.2026.04.005_bib0069","doi-asserted-by":"crossref","DOI":"10.1016\/j.jphotochem.2020.112837","article-title":"Riboflavin degradation products; combined photochemical and mass spectrometry approach","volume":"403","author":"Insi\u0144ska-Rak","year":"2020","journal-title":"J Photochem Photobiol A-Chem"},{"key":"10.1016\/j.clindermatol.2026.04.005_bib0070","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.jphotobiol.2015.10.030","article-title":"Riboflavin acetate induces apoptosis in squamous carcinoma cells after photodynamic therapy","volume":"153","author":"Juarez","year":"2015","journal-title":"J Photochem Photobiol B"},{"key":"10.1016\/j.clindermatol.2026.04.005_bib0071","doi-asserted-by":"crossref","DOI":"10.1016\/j.jphotobiol.2019.04.005","article-title":"An experimental study on riboflavin photosensitization treatment for inactivation of circulating HCT116 tumor cells","volume":"196","author":"Yu","year":"2019","journal-title":"J Photochem Photobiol B"},{"key":"10.1016\/j.clindermatol.2026.04.005_bib0072","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1111\/php.13806","article-title":"Tetraacetyl riboflavin derivative mediates caspase 3\/7 activation via MAPK in A431 cells upon blue light influence","volume":"100","author":"Buniowska","year":"2024","journal-title":"Photochem Photobiol"},{"key":"10.1016\/j.clindermatol.2026.04.005_bib0073","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.freeradbiomed.2024.01.019","article-title":"Redox modulation of oxidatively-induced DNA damage by ascorbate enhances both in vitro and ex-vivo DNA damage formation and cell death in melanoma cells","volume":"213","author":"Najeeb","year":"2024","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.clindermatol.2026.04.005_bib0074","doi-asserted-by":"crossref","first-page":"254","DOI":"10.3390\/cells12020254","article-title":"High-dose ascorbate in combination with anti-PD1 checkpoint inhibition as treatment option for malignant melanoma","volume":"12","author":"Burkard","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.clindermatol.2026.04.005_bib0075","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0304-3835(03)00278-7","article-title":"Cancer chemopreventive effects of oral feeding \u03b1-tocopherol on ultraviolet light B induced photocarcinogenesis of hairless mouse","volume":"196","author":"Kuchide","year":"2003","journal-title":"Cancer Lett"},{"key":"10.1016\/j.clindermatol.2026.04.005_bib0076","doi-asserted-by":"crossref","first-page":"3551","DOI":"10.2147\/CMAR.S389591","article-title":"The chemoprotective role of vitamin D in skin cancer: a systematic review","volume":"14","author":"Sutedja","year":"2022","journal-title":"Cancer Manag Res"},{"key":"10.1016\/j.clindermatol.2026.04.005_bib0077","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.3390\/nu13061931","article-title":"Vitamin D supplementation and disease-free survival in stage ii melanoma: a randomized placebo controlled trial","volume":"13","author":"Johansson","year":"2021","journal-title":"Nutrients"},{"key":"10.1016\/j.clindermatol.2026.04.005_bib0078","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1002\/cncr.34718","article-title":"Vitamin D supplementation increases objective response rate and prolongs progression-free time in patients with advanced melanoma undergoing anti-PD-1 therapy","volume":"129","author":"Galus","year":"2023","journal-title":"Cancer"},{"key":"10.1016\/j.clindermatol.2026.04.005_bib0079","doi-asserted-by":"crossref","first-page":"96","DOI":"10.3892\/ijo.2022.5386","article-title":"CYP11A1-derived vitamin D hydroxyderivatives as candidates for therapy of basal and squamous cell carcinomas","volume":"61","author":"Slominski","year":"2022","journal-title":"Int J Oncol"}],"container-title":["Clinics in Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738081X2600091X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738081X2600091X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T07:21:21Z","timestamp":1780039281000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0738081X2600091X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":79,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S0738081X2600091X"],"URL":"https:\/\/doi.org\/10.1016\/j.clindermatol.2026.04.005","relation":{},"ISSN":["0738-081X"],"issn-type":[{"value":"0738-081X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Skin cancer and vitamins: In theory and practice","name":"articletitle","label":"Article Title"},{"value":"Clinics in Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clindermatol.2026.04.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}